. . . . . . . "[Phosphoinositide-3 kinase (PI3K) pathway activation contributes to mantle cell lymphoma (MCL) pathogenesis, but early-phase studies of the PI3K p110? inhibitor GS-1101 have reported inferior responses in MCL compared with other non-Hodgkin lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:25+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .